Results 261 to 270 of about 93,339 (287)
Some of the next articles are maybe not open access.
Age-related macular degeneration
NursingAbstract: Age-related macular degeneration (AMD) is the leading cause of visual impairment in patients age 50 and older, with an estimated 200 million people affected worldwide and a projected 288 million by 2040. This article provides an overview of the epidemiology, risk factors, pathophysiology, clinical manifestations, diagnosis ...
Monika, Fleckenstein +2 more
openaire +4 more sources
Age‐Related Macular Degeneration
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013Age‐related macular degeneration ( AMD ) is the leading cause of blindness in the elderly, and the prevalence of the disease increases exponentially with every decade after age 50 years. It is a multifactorial disease involving a complex interplay of genetic, environmental, metabolic, and ...
Lily K, Cheung, Angie, Eaton
openaire +2 more sources
Age-related macular degeneration
Insight - the Journal of the American Society of Ophthalmic Registered Nurses, 1997Age-related macular degeneration (AMD) is one of the leading causes of legal blindness among older adults. Early recognition of AMD is important because treatment can enable patients to maintain central vision longer. Nurses who understand the effects of AMD can teach their elderly patients ways to slow its progression, such as increasing consumption ...
openaire +3 more sources
Neovascular Age-Related Macular Degeneration
Ophthalmologica, 2012<i>Purpose:</i> Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an increasing incidence as the elderly population expands. Large, multi-center, randomized, clinical trials have been conducted exploring the safety and efficacy of anti-VEGF treatments. This paper aims to discuss the safety and efficacy
VERITTI, Daniele +2 more
openaire +2 more sources
Cystoid Macular Degeneration in Exudative Age-Related Macular Degeneration
American Journal of Ophthalmology, 2011To investigate the prevalence and clinical significance of cystoid macular degeneration in eyes that underwent intravitreal ranibizumab injections for exudative age-related macular degeneration.Retrospective, interventional case series.We reviewed the charts of 56 consecutive patients (19 male, 37 female; mean age ± standard deviation, 80.81 ± 4.8 ...
QUERQUES , GIUSEPPE +5 more
openaire +4 more sources
Radiotherapy for age-related macular degeneration
Clinical Oncology, 1998retina is dependent upon the choroid for its metabolic needs, and the thickening of Bruch's membrane hampers metabolic exchange between the choroid and the pigment epithelium. The precise mechanism by which this induces CNV is unknown. Recent data suggest that vascular endothelial growth factor (VEGF), a specific endothelial cell mitogen, is released ...
S J, Gibbs +3 more
openaire +2 more sources
Age‐related macular degeneration in Inuit
Acta Ophthalmologica Scandinavica, 1999To describe a specific Greenlandic type af age-related macular degeneration (AMD) - the Retinochoroidal Atrophy (RCA).135 referred patients in East Greenland were examined in 1997. A colour and a redfree fundus photograph of an 87-year-old Greenlandic woman illustrates the clinical picture of RCA (retinochoriodal atrophy).Of 135 examined patients 22 ...
openaire +2 more sources
Age-Related Macular Degeneration
New England Journal of Medicine, 2000S L, Fine +3 more
openaire +2 more sources
Age-related macular degeneration
British Journal of Hospital Medicine, 2016B B, Ong, F G, Ah-Fat
openaire +2 more sources
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
Ophthalmology, 2020David Sarraf +2 more
exaly